13 Results

People

  1. Kris
    Kris
  2. Fury
    Fury
  3. Krug
    Krug
  4. Rizvi
    Rizvi
  5. Azzoli
    Azzoli
  6. Ginsberg
    Ginsberg
  7. Miller
    Miller
  8. Paik
    Paik
  9. Rigas
    Rigas
  10. Schwartz
    Schwartz

Groups

  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Radiology, Department of (5)
  4. Thoracic Oncology (5)
  5. Body Imaging Service (4)
  6. Gastrointestinal Oncology Service (3)
  7. Nursing (3)
  8. Biostatistics Service (2)
  9. Center for Pancreatic Cancer Research (2)
  10. Epidemiology and Biostatistics (2)
  1. "anemia"
  2. "Cancer Chemotherapy and Pharmacology"
Formats
  1. Journal Article (13)
Groups
  1. Department of Medicine (10)
  2. Solid Tumor Oncology Division (10)
  3. Radiology, Department of (5)
  4. Thoracic Oncology (5)
  5. Body Imaging Service (4)
  6. Gastrointestinal Oncology Service (3)

More Groups

People
  1. Mark Kris (5)
  2. Lee Krug (3)
  3. Matthew Fury (3)
  4. Naiyer Rizvi (3)
  5. Camelia Sima (2)
  6. Christopher Azzoli (2)

More People

Years
  1. 2013 (2)
  2. 2012 (2)
  3. 2011 (2)
  4. 2010 (2)
  5. 2008 (1)
  6. 2006 (1)

More Years

Publications
  1. Cancer Chemotherapy and Pharmacology (13)
Publishers
  1. Springer (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Picus, J.; Hussain, A.; Ellard, S.; Chi, K. N.; Nydam, T.; Allen-Freda, E.; Mishra, K. K.; Porro, M. G.; Scher, H. I.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A.; Katabi, N.; Sima, C.; Kelly, K. W.; Nwankwo, O.; Haque, S.; Pfister, D. G.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
    Journal Article

    De Jesus-Acosta, A.; Oliver, G. R.; Blackford, A.; Kinsman, K.; Flores, E. I.; Wilfong, L. S.; Zheng, L.; Donehower, R. C.; Cosgrove, D.; Laheru, D.; more...
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: An Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial
    Journal Article

    Cianfrocca, M.; Lee, S.; Von Roenn, J.; Rudek, M. A.; Dezube, B. J.; Krown, S. E.; Sparano, J. A.
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Chan, S. L.; Lin, C. C.; Chiorean, E. G.; Holcombe, R. F.; Mulcahy, M. F.; Carter, W. D.; Patel, K.; Wilson, W. R.; Melink, T. J.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
    Journal Article

    Paik, P. K.; Rudin, C. M.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; Markus, S.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
    Journal Article

    Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2008)

    Fulltext@MSK | Save
  • A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors
    Journal Article

    Fury, M. G.; Krug, L. M.; Azzoli, C. G.; Sharma, S.; Kemeny, N.; Wu, N.; Kris, M. G.; Rizvi, N. A.
    Cancer Chemotherapy and Pharmacology (2006)

    Fulltext@MSK | Save